Insulin-like growth factor and epidermal growth factor treatment: New approaches to protecting steatotic livers against ischemia-reperfusion injury

Endocrinology

Volumn 150, Issue 7, 2009, Pages 3153-3161

  Casillas Ramírez, Araní ^a   Zaouali, Amine ^b   Padrissa Altés, Susagna ^b   Mosbah, Ismail Ben ^b   Pertosa, Anna ^b   Alfany Fernández, Izabel ^a   Bintanel Morcillo, Maria ^a   Xaus, Carme ^b   Rimola, Antoni ^c,d   Rodés, Juan ^c,d   Roselló Catafau, Joan ^a,b,c   Peralta, Carmen ^a,c  

^a CSIC   (Spain)

^b INST D INVESTIGACIONS B   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANISOMYCIN; EPIDERMAL GROWTH FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; ROSIGLITAZONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FATTY LIVER; LIVER ISCHEMIA; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REPERFUSION INJURY; THERAPY EFFECT;

ANIMALS; EPIDERMAL GROWTH FACTOR; FATTY LIVER; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIVER; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PPAR GAMMA; RATS; RATS, ZUCKER; REPERFUSION INJURY;

EID: 67649654475     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1458     Document Type: Article

References (59)

1. Peralta C, Roselló -Catafau J 2004 The future of fatty livers. J Hepatol 41: 149-151 (Pubitemid 39005167)
2. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, NagorneyDM 1998 Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 2:292-298
3. Selzner M, Clavien PA 1999 Resection of liver tumors: special emphasis on neoadjuvant and adjuvant therapy. In: Clavien PA, ed. Malignant liver tumors: current and emerging therapies. Malden, MA: Blackwell Science; 137-149
4. Canelo R, Braun F, Sattler B, Klinge B, Lorf T, Ramadori G, Ringe B 1999 Is a fatty liver dangerous for transplantation? Transplant Proc 31:414-415
5. D'Alessandro AM, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knechtle SJ, Pirsch JD, Hafez GR, Lorentzen D, BelzerFO1991 The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 51:157-163
6. Ding H, Kopple JD,CohenA, HirschbergR1993 Recombinanthumaninsulinlike growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 91:2281-2287 (Pubitemid 23141506)
7. Holt RI, Crossey PA, Jones JS, Baker AJ, Portmann B, Miell JP 1997 Hepatic growth hormone receptor, insulin-like growth factor I, and insulin-like growth factor-binding protein messenger RNA expression in pediatric liver disease. Hepatology 26:1600-1606 (Pubitemid 27520029)
8. Chen JW, Nielsen MF, Caumo A, Vilstrup H, Christiansen JS, Frystyk J 2006 Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis. Eur J Endocrinol 155:285-292 (Pubitemid 44269445)
9. Cusi K, DeFronzo R 2000 Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance. J Clin Endocrinol Metab 85:3077-3084 (Pubitemid 30944506)
10. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson DM, RosenfeldRG 1996 Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28:619-637
11. Holt RI, Baker AJ, Miell JP 1997 The pathogenesis of growth failure in paediatric liver disease. J Hepatol 27:413-423 (Pubitemid 27366225)
12. Barreca A, Voci A, Minuto F, de Marchis M, Cecchelli E, Fugassa E, Giordano G, Gallo G 1992 Effect of epidermal growth factor on insulin-like growth factor-I (IGF-I) and IGF-binding protein synthesis by adult rat hepatocytes. Mol Cell Endocrinol 84:119-126
13. Rogers SA, Miller SB, Hammerman MR 1991 Insulin-like growth factor I gene expression in isolated rat renal collecting duct is stimulated by epidermal growth factor. J Clin Invest 87:347-351
14. van Neck JW, Berghout EM, Vinter-Jensen L, Groffen CA, Cingel V, Dits NF, Drop SL, Flyvbjerg A 2000 The effect of epidermal growth factor and IGF-I infusion on hepatic and renal expression of the IGF-system in adult female rats. J Endocrinol 165:115-122 (Pubitemid 30210571)
15. Harada N, Okajima K, Kurihara H, Nakagata N 2007 Stimulation of sensory neurons by capsaicin increases tissue levels of IGF-I, thereby reducing reperfusion- induced apoptosis in mice. Neuropharmacology 52:1303-1311 (Pubitemid 46527704)
16. Massip-Salcedo M, Casillas-Ramirez A, Franco-Gou R, Bartrons R, Ben Mosbah I, Serafin A, Roselló -Catafau J, Peralta C 2006 Heat shock proteins and mitogenactivated protein kinases in steatotic livers undergoing ischemia-reperfusion:some answers. Am J Pathol 168:1474-1485
17. Casillas-Ramirez A, Amine-Zaouali M, Massip-Salcedo M, Padrissa-Altés S, Bintanel-Morcillo M, Ramalho F, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló -Catafau J, Peralta C 2008 Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury. Crit Care Med 36: 1256-1266
18. Yamagishi S, Matsumoto T, Yokomaku D, Hatanaka H, Shimoke K, Yamada M, Ikeuchi T 2003 Comparison of inhibitory effects of brain-derived neurotrophic factor and insulin-like growth factor on low potassium-induced apoptosis and activation of p38 MAPK and c-Jun in cultured cerebellar granule neurons. Brain Res Mol Brain Res 119:184-191 (Pubitemid 37415091)
19. Bogazzi F, Ultimieri F, Raggi F, Costa A, Gasperi M, Cecconi E, Mosca F, Bartalena L, Martino E 2002 Peroxisome proliferator activated receptor γ expression is reduced in the colonic mucosa of acromegalic patients. J Clin Endocrinol Metab 87:2403-2406 (Pubitemid 34521538)
20. Zhou Y, Zheng S, Lin J, Zhang QJ, ChenA2007 The interruption of thePDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARγ in rat activated hepatic stellate cell in vitro. Lab Invest 87:488-498 (Pubitemid 46633122)
21. Houde M, Laprise P, Jean D, Blais M, Asselin C, Rivard N 2001 Intestinal epithelial cell differentiation involves activation of p38 mitogen-activated protein kinase that regulates the homeobox transcription factor CDX2. J Biol Chem 276:21885-21894 (Pubitemid 37413193)
22. Nolan CJ, Leahy JL, Delghingaro-Augusto V, Moibi J, Soni K, Peyot ML, Fortier M, Guay C, Lamontagne J, Barbeau A, Przybytkowski E, Joly E, Masiello P, Wang S, Mitchell GA, Prentki M 2006 β-Cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signaling. Diabetologia 49:2120-2130 (Pubitemid 44168480)
23. Liu YQ, Jetton TL, Leahy JL 2002 β-Cell adaptation to insulin resistance. Increased pyruvate carboxylase and malate-pyruvate shuttle activity in islets of nondiabetic Zucker fatty rats. J Biol Chem 277:39163-39168 (Pubitemid 35190884)
24. Franklin SC, Moulton M, Sicard GA, Hammerman MR, Miller SB 1997 Insulin-like growth factor I preserves renal function postoperatively. Am J Physiol F 272:257-259 (Pubitemid 27382269)
25. Castilla-Cortázar I, Picardi A, Tosar A, Ainzú a J, Urdaneta E, García M, Pascual M, Quiroga J, Prieto J 1999 Effect of insulin-like growth factor I on in vivo intestinal absorption of D-galactose in cirrhotic rats. Am J Physiol 276:G37-G42
26. Tomaszewska R, Dembiń ski A, Warzecha Z, Ceranowicz P, Konturek SJ, Stachura J 2002 The influence of epidermal growth factor on the course of ischemia- reperfusion induced pancreatitis in rats. J Physiol Pharmacol 53:183-198
27. Zhao TC, Taher MM, Valerie KC, Kukreja RC 2001 p38 triggers late preconditioning elicited by anisomycin in heart: involvement of NF-κB and iNOS. Circ Res 89:915-922 (Pubitemid 34627897)
28. Lang CH, Liu X, Nystrom GJ, Frost RA 2000 Acute response of IGF-I and IGF binding proteins induced by thermal injury. Am J Physiol Endocrinol Metab 278:E1087-E1096 (Pubitemid 30439147)
29. KimHL,ChoYS, Choi H,Chun YS, Lee ZH, Park JW 2009 Hypoxia-inducible factor 1 is deregulated by the serum of rats with adjuvant-induced arthritis. Biochem Biophys Res Commun 378:123-128
30. Powolny AA, Wang S, Carlton PS, Hoot DR, Clinton SK 2008 Interrelationships between dietary restriction, the IGF-I axis, and expression of vascular endothelial growth factor by prostate adenocarcinoma in rats. Mol Carcinog 47:458-465 (Pubitemid 351822304)
31. Serafín A, Roselló -Catafau J, Prats N, Gelpí E, Rodés J, Peralta C 2004 Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 39:688-698 (Pubitemid 38337648)
32. Camargo Jr CA,Madden JF,Gao W,Selvan RS, Clavien PA 1997 Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26:1513-1520 (Pubitemid 27520017)
33. Lang CH, Liu X, Nystrom G,WuD, Cooney RN, Frost RA2000 Acute effects of growth hormone in alcohol-fed rats. Alcohol 35:148-158 (Pubitemid 30248617)
34. Mirpuri E, García-Trevijano ER, Castilla-Cortazar I, Berasain C, Quiroga J, Rodriguez-Ortigosa C, Mato JM, Prieto J, Avila MA 2002 Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I. Int J Biochem Cell Biol 34:242-252 (Pubitemid 34159139)
35. Frystyk J, Delhanty PJ, Skjaerbaek C, Baxter RC 1999 Changes in the circulating IGF system during short-term fasting and refeeding in rats.AmJ Physiol 277:E245-E252
36. Lang CH, Fan J, Cooney R, Vary TC 1996 IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis. Am J Physiol 270:E430-E437 (Pubitemid 126756371)
37. GranadoM,Martín AI, Ló pez-MenduiñaM,Ló pez-Calderón A, Villanú aMA 2008 GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia. Am J Physiol Endocrinol Metab 294:E131-E141
38. Blomsma MC, de Knegt RJ, Dullaart RP, Jansen PL 1997 Insulin-like growth factor-I in liver cirrhosis. J Hepatol 27:1133-1138 (Pubitemid 27523976)
39. Soszynski PA, Frohman LA 1992 Inhibitory effects of ethanol on the growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-I axis in the rat. Endocrinology 131:2603-2608
40. Laron Z 1996 Short stature due to genetic defects affecting growth hormone activity. N Engl J Med 334:463-465 (Pubitemid 26055849)
41. Donaghy AJ, Baxter RC 1996 Insulin-like growth factor bioactivity and its modification in growth hormone resistant states. Baillieres Clin Endocrinol Metab 10:421-446 (Pubitemid 26258123)
42. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D 2002 Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781 (Pubitemid 35050954)
43. Boisclair YR, Rhoads RP, Ueki I,WangJ, Ooi GT 2001 The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. J Endocrinol 170:63-70 (Pubitemid 32677567)
44. Woelfle J, Rotwein P 2004 In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. Am J Physiol Endocrinol Metab 286:E393-E401
45. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
46. Goda N, Tenno T, Inomata K, Shirakawa M, Tanaka T, Hiroaki H 2008 Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5. Exp Cell Res 314:2352-2361
47. Takaoka M, Smith CE, Mashiba MK, Okawa T, Andl CD, El-Deiry WS, Nakagawa H 2006 EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I. Am J Physiol Gastrointest Liver Physiol 290:G404-G416
48. Bhattacharyya N, Pechhold K, Shahjee H, Zappala G, Elbi C, Raaka B, Wiench M, Hong J, RechlerMM2006 Nonsecreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus. J Biol Chem 281:24588-24601 (Pubitemid 44274233)
49. Chen X, Ferry Jr RJ 2006 Novel actions of IGFBP-3 on intracellular signaling pathways of insulin-secreting cells. Growth Horm IGF Res [Erratum (2006) 16:276] 16:41-48 (Pubitemid 43205313)
50. Shaikh S, Bloomfield FH, BauerMK,Phua HH, Gilmour RS, Harding JE 2005 Amniotic IGF-I supplementation of growth-restricted fetal sheep alters IGF-I and IGF receptor type 1mRNAand protein levels in placental and fetal tissues. J Endocrinol 186:145-155 (Pubitemid 41015672)
51. Liao L, Dearth RK, Zhou S, Britton OL, Lee AV, Xu J 2006 Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency. Endocrinology 147:3877-3888 (Pubitemid 44079393)
52. Donaghy AJ, Delhanty PJ, Ho KK, Williams R, Baxter RC 2002 Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis. J Hepatol 36:751-758 (Pubitemid 35177403)
53. Casillas-Ramírez A, Mosbah IB, Ramalho F, Roselló -Catafau J, Peralta C 2006 Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 79:1881-1894 (Pubitemid 44488610)
54. Ramírez I, Tebar F, Grau M, SoleyM1995 Role of heterotrimeric G-proteins in epidermal growth factor signalling. Cell Signal 7:301-311
55. Kholodenko BN, Demin OV, Moehren G, Hoek JB 1999 Quantification of short term signaling by the epidermal growth factor receptor. J Biol Chem 274:30169-30181 (Pubitemid 29483404)
56. Marino M, Spagnuolo S, Cavallini M, Terenzi F, Mangiantini MT, Leoni S 1996 EGF responsiveness of hepatocytes after partial hepatectomy. Cell Signal 8:555-559 (Pubitemid 27035930)
57. Angulo P 2002 Nonalcoholic fatty liver disease.NEngl JMed346:1221-1231
58. Veteläinen R, van Vliet A, Gouma DJ, van Gulik TM 2007 Steatosis as a risk factor in liver surgery. Ann Surg 245:20-30 (Pubitemid 46035431)
59. Farrell GC, Teoh NC, McCuskey RS 2008 Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken) 291:684-692